Tenon Medical, Inc. (TNON)
NASDAQ: TNON · IEX Real-Time Price · USD
0.765
+0.054 (7.67%)
At close: Apr 24, 2024, 2:43 PM
0.750
-0.015 (-1.91%)
After-hours: Apr 24, 2024, 5:05 PM EDT
Tenon Medical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Tenon Medical stock has a target of 3.00, which predicts an increase of 292.36% from the current stock price of 0.76.
Analyst Consensus: Buy
Analyst Ratings
According to 1 stock analyst, the rating for Tenon Medical is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Maintains $5 → $3 | Buy | Maintains | $5 → $3 | +292.36% | Apr 15, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +7,747.24% | Mar 10, 2023 |
| Benchmark | Benchmark | Buy Initiates $60 | Buy | Initiates | $60 | +7,747.24% | Jun 21, 2022 |
Financial Forecast
Revenue This Year
4.95M
from 2.93M
Increased by 68.99%
Revenue Next Year
9.37M
from 4.95M
Increased by 89.37%
EPS This Year
-3.22
from -8.59
EPS Next Year
-2.33
from -3.22
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 5.3M | 11.0M |
| Avg | 4.9M | 9.4M |
| Low | 4.6M | 7.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | 80.5% | 121.4% |
| Avg | 69.0% | 89.4% |
| Low | 56.3% | 57.3% |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -1.94 | -1.50 |
| Avg | -3.22 | -2.33 |
| Low | -4.37 | -3.07 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.